首页> 外文期刊>国际肝胆胰疾病杂志(英文版) >Signiifcance of pathological positive superior mesenteric/portal venous invasion in pancreatic cancer
【24h】

Signiifcance of pathological positive superior mesenteric/portal venous invasion in pancreatic cancer

机译:病理阳性肠系膜上/门静脉侵犯在胰腺癌中的意义

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: Pancreaticoduodenectomy with superior mesenteric/portal venous resection for pancreatic ductal ad-enocarcinoma (PDAC) is frequently performed with no added morbidity or mortality in case of tumor abutment to the su-perior mesenteric or portal vein so as to obtain a margin nega-tive resection. True histopathological portal vein invasion is found only in a small subset of such patients. The aim of this review aimed to discuss the signiifcance of histopathological venous invasion in PDAC. DATA SOURCES: For this review available data was searched from PubMed and analyzed. No randomized trials have been published on this topic. RESULTS: Existing data on prognostic factors in histopatho-logical venous invasion by PDAC are limited and recent stud-ies indicate worse survival in this subgroup of patients. In addition, venous invasion in PDAC has been associated with large tumors, involved lymph nodes, perineural invasion and R1 resection. The survival of patients with portal venous re-section but without histologic venous invasion is reportedly better than those with histopathological venous invasion;though conlficting studies do exist on the subject. Some stud-ies also relate the depth of venous invasion to prognosis after surgical resection of PDAC. CONCLUSIONS: Frank/‘histopathological’ invasion of supe-rior mesenteric/portal venous and R1 resection indicate a very poor survival. Such patients may be given the opportunity of beneift of neoadjuvant treatment.
机译:背景:胰十二指肠切除术结合上肠系膜/门静脉上切除术治疗胰腺导管上皮癌(PDAC),在肿瘤邻接于上肠系膜上或门静脉的情况下,通常不会增加发病率或死亡率,从而获得边缘阴性。活动性切除。真正的组织病理学门静脉侵犯仅在此类患者的一小部分中发现。这篇综述的目的是讨论组织病理学静脉侵袭在PDAC中的意义。 数据来源:对于本评价,从PubMed搜索了可用数据并进行了分析。没有关于该主题的随机试验发表。 结果:有关PDAC的组织病理学静脉侵袭的预后因素的现有数据有限,最近的研究表明该患者亚组的生存期较差。此外,PDAC中的静脉浸润与大肿瘤,淋巴结肿大,神经周浸润和R1切除有关。据报道,门静脉切除但无组织学静脉浸润的患者的存活率要好于组织病理学静脉浸润的患者;尽管有确凿的研究。一些研究还将静脉浸润的深度与PDAC手术切除后的预后相关。 结论:Frank /“组织病理学”侵袭上肠系膜/门静脉和R1切除术表明生存率很低。可以给这类患者新辅助治疗的机会。

著录项

  • 来源
    《国际肝胆胰疾病杂志(英文版)》 |2016年第6期|572-578|共7页
  • 作者

    Mallika Tewari;

  • 作者单位

    Hepato Pancreatico Biliary and Gastrointestinal Di-vision, Department of Surgical Oncology, Institute of Medical Sciences, Banaras Hindu University, Varanasi -221005 U.P., India;

  • 收录信息 中国科学引文数据库(CSCD);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-19 03:39:14
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号